IQV Stock Brushes 52-Week Low, Dips to $168.99

In a challenging market environment, IQVIA Holdings Inc. (NYSE:IQV) stock has touched a new 52-week low, sinking to $168.99. The company, a $29.9 billion market cap player in the healthcare and pharmaceutical analytics space, has faced headwinds that have pressured its stock price over the past year. According to InvestingPro data, analysts maintain a strong buy consensus with potential upside to their target prices. Investors have watched with concern as IQVIA’s shares have steadily declined, marking a significant 1-year change with a drop of -29.03%. While this downturn reflects broader market trends, InvestingPro analysis suggests the stock may be undervalued, with management actively buying back shares. The company maintains a GOOD financial health score, generating $15.4 billion in revenue. For deeper insights into IQVIA’s valuation and 8 additional exclusive ProTips, explore the comprehensive Pro Research Report available on InvestingPro.

In other recent news, IQVIA Holdings Inc. reported its fourth-quarter 2024 earnings, with adjusted diluted earnings per share (EPS) of $3.12, slightly exceeding the forecast of $3.11. The company’s revenue reached $3.96 billion, surpassing the expected $3.93 billion, while full-year 2024 revenue was reported at $15.405 billion, marking a 2.8% year-over-year increase. In a strategic financial move, IQVIA refinanced its debt, reducing the interest rate on its Term B dollar loans, which is expected to optimize its capital structure and improve profitability. Analyst firms have shown confidence in IQVIA’s future, with TD Cowen maintaining a Buy rating and a $250 price target, and Truist Securities raising their price target to $263, also reiterating a Buy rating. Morgan Stanley (NYSE:MS) has increased its price target for IQVIA shares to $250, citing strong performance in the company’s Research & Development Solutions sector. These developments reflect a positive outlook for IQVIA, supported by strategic initiatives and robust financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.